Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer

Niranjan J. Sathianathen, Philipp Dahm, Sarah Jane Brown, Makinna Oestreich, Shilpa Gupta, Badrinath R Konety, Frank Kunath

Research output: Contribution to journalArticle

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of early abiraterone acetate in combination with androgen deprivation therapy for newly diagnosed metastatic hormone-sensitive prostate cancer.

Original languageEnglish (US)
Article numberCD013245
JournalCochrane Database of Systematic Reviews
Volume2019
Issue number1
DOIs
StatePublished - Jan 24 2019

Fingerprint

Androgens
Prostatic Neoplasms
Hormones
Therapeutics
Abiraterone Acetate

Cite this

Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer. / Sathianathen, Niranjan J.; Dahm, Philipp; Brown, Sarah Jane; Oestreich, Makinna; Gupta, Shilpa; Konety, Badrinath R; Kunath, Frank.

In: Cochrane Database of Systematic Reviews, Vol. 2019, No. 1, CD013245, 24.01.2019.

Research output: Contribution to journalArticle

@article{545b3f79ff1143b587a83ef0a0641dad,
title = "Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer",
abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of early abiraterone acetate in combination with androgen deprivation therapy for newly diagnosed metastatic hormone-sensitive prostate cancer.",
author = "Sathianathen, {Niranjan J.} and Philipp Dahm and Brown, {Sarah Jane} and Makinna Oestreich and Shilpa Gupta and Konety, {Badrinath R} and Frank Kunath",
year = "2019",
month = "1",
day = "24",
doi = "10.1002/14651858.CD013245",
language = "English (US)",
volume = "2019",
journal = "The Cochrane database of systematic reviews",
issn = "1361-6137",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer

AU - Sathianathen, Niranjan J.

AU - Dahm, Philipp

AU - Brown, Sarah Jane

AU - Oestreich, Makinna

AU - Gupta, Shilpa

AU - Konety, Badrinath R

AU - Kunath, Frank

PY - 2019/1/24

Y1 - 2019/1/24

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of early abiraterone acetate in combination with androgen deprivation therapy for newly diagnosed metastatic hormone-sensitive prostate cancer.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of early abiraterone acetate in combination with androgen deprivation therapy for newly diagnosed metastatic hormone-sensitive prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=85060402305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060402305&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD013245

DO - 10.1002/14651858.CD013245

M3 - Article

VL - 2019

JO - The Cochrane database of systematic reviews

JF - The Cochrane database of systematic reviews

SN - 1361-6137

IS - 1

M1 - CD013245

ER -